VRTX
VERTEX PHARMACEUTICALS INC / MA
NASDAQ · Healthcare · Biotechnology · US
$508.14
−1.59%Forward multiples
Based on analyst estimates
- P/E forward
- 26.42x
- P/E 2026E
- 27.10x
- P/E 2027E
- 23.95x
- P/E 2028E
- 20.04x
- P/S forward
- 9.28x
Trailing multiples
Trailing twelve months
- P/E TTM
- 29.34x
- PEG TTM
- 2.65x
- Price / book
- 6.36x
- Price / sales
- 10.20x
- Price / cash flow
- 30.00x
Enterprise value
- Enterprise value
- $122.9B
- EV / sales
- 9.74x
- EV / EBITDA
- 22.58x
- EV / EBIT
- 25.23x
- Market cap
- $128.8B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026